Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

Detalles Bibliográficos
Autores principales: Jamieson, Stephen M.F., Tsai, Peter, Kondratyev, Maria K., Budhani, Pratha, Liu, Arthur, Senzer, Neil N., Chiorean, E. Gabriela, Jalal, Shadia I., Nemunaitis, John J., Kee, Dennis, Shome, Avik, Wong, Way W., Li, Dan, Poonawala-Lohani, Nooriyah, Kakadia, Purvi M., Knowlton, Nicholas S., Lynch, Courtney R.H., Hong, Cho R., Lee, Tet Woo, Grénman, Reidar A., Caporiccio, Laura, McKee, Trevor D., Zaidi, Mark, Butt, Sehrish, Macann, Andrew M.J., McIvor, Nicholas P., Chaplin, John M., Hicks, Kevin O., Bohlander, Stefan K., Wouters, Bradly G., Hart, Charles P., Print, Cristin G., Wilson, William R., Curran, Michael A., Hunter, Francis W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990753/
https://www.ncbi.nlm.nih.gov/pubmed/36810255
http://dx.doi.org/10.1172/jci.insight.169136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990753/
https://www.ncbi.nlm.nih.gov/pubmed/36810255
http://dx.doi.org/10.1172/jci.insight.169136

Ejemplares similares